In Brief: Visx/Laser Vision Centers

Visx/Laser Vision Centers: Sign purchasing contract under which LVC agrees to buy 20 Visx Star ophthalmic excimer laser systems "subject to Visx' production schedule," LVC states. The deal, which includes an option to purchase up to 20 additional units over the next year, would be worth "over $20 mil." if fully exercised, according to LVC. The Visx laser is approved for phototherapeutic keratectomy; on Oct. 20 the device received a conditional approval recommendation from FDA's Ophthalmic Devices Advisory Panel for use in photorefractive keratectomy ("The Gray Sheet" Oct. 23, I&W-21)...